Evidence map›Paper›PMID 35856439›Full record

ReviewInternational journal of oncology2022

Glioma‑neuronal interactions in tumor progression: Mechanism, therapeutic strategies and perspectives (Review).

Tianzhen Hua, Huanxiao Shi, Mengmei Zhu, Chao Chen, Yandong Su, Shengjia Wen, Xu Zhang, Juxiang Chen, Qilin Huang, Hongxiang Wang

Open access · bronzeAbstract readReview
In one paragraph

Review in International journal of oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Regulation ofFrontiers in molecular neuroscience · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Glioma neuron symbiosis: a hypothesis.Frontiers in neuroscience · 2025
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. The Role of Hyperexcitability in Gliomagenesis.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Tianzhen Hua *Department of Neurosurgery, Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Huanxiao Shi *Department of Neurosurgery, Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Mengmei Zhu *Department of Neurosurgery, Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Chao ChenDepartment of Neurosurgery, Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Yandong SuDepartment of Neurosurgery, Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Shengjia WenDepartment of Neurosurgery, Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Xu ZhangDepartment of Neurosurgery, Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Juxiang ChenDepartment of Neurosurgery, Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Qilin HuangDepartment of Neurosurgery, General Hospital of Central Theater Command of Chinese People's Liberation Army, Wuhan, Hubei 430070, P.R. China.
Hongxiang WangDepartment of Neurosurgery, Changhai Hospital, Naval Medical University, Shanghai 200433, P.R. China.
Second Military Medical University · CNChinese People's Liberation Army · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An increasing body of evidence has become available to reveal the synaptic and functional integration of glioma into the brain network, facilitating tumor progression. The novel discovery of glioma‑neuronal interactions has fundamentally challenged our understanding of this refractory disease. The present review aimed to provide an overview of how the neuronal activities function through synapses, neurotransmitters, ion channels, gap junctions, tumor microtubes and neuronal molecules to establish communications with glioma, as well as a simplified explanation of the reciprocal effects of crosstalk on neuronal pathophysiology. In addition, the current state of therapeutic avenues targeting critical factors involved in glioma‑euronal interactions is discussed and an overview of clinical trial data for further investigation is provided. Finally, newly emerging technologies, including immunomodulation, a neural stem cell‑based delivery system, optogenetics techniques and co‑culture of neuron organoids and glioma, are proposed, which may pave a way towards gaining deeper insight into both the mechanisms associated with neuron‑ and glioma‑communicating networks and the development of therapeutic strategies to target this currently lethal brain tumor.

Indexed as

Brain NeoplasmsGliomaHumansNeuronsOptogeneticsSynapsesgliomaneuronneurotransmittersynapsetumor microenvironment

Identifiers

PMID35856439
PMCPMC9339490
OpenAlexW4285007928

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.